In our database, we cover for all the significant and strongly associated genetic markers under each category type. We have extensively accounted for markers tested in various populations, particularly focusing on those studied in the Asian population. Utilizing advanced next generation sequencing technology, Circle is able to analyze over 3 million data points, which is more than 5 times the amount of data analyzed by leading companies such as 23andMe and Ancestry.com, both of which employ genotyping technology.
When conducting targeted sequencing, unlike other personal genomic testing companies that screen for specific variants in genes, we can specifically search for novel mutations present in cancer genes. This approach significantly reduces the likelihood of missing out on hundreds of other mutations that may be overlooked using genotyping technology.